Until now, studies reported in the literature showed that circPVT1 exerts oncogenic activity in breast cancer by sponging miR-181a-2-3p and miR-29a-3p, followed by increased invasion and drug resistance and supporting breast cancer progression through the HIF-1α pathway [55,56]. This evidence concerns the gene HIF1A and breast carcinoma.